Aqr Capital Management LLC Ptc Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 189,579 shares of PTCT stock, worth $9.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

189,579

Previous 68,912 175.1%

Holding current value

$9.22 Million

Previous $2.11 Million 233.79%

% of portfolio

0.01%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $3.67 Million - $4.54 Million	120,667 Added 175.1%	189,579 $7.03 Million
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $1.28 Million - $2.09 Million	52,019 Added 307.93%	68,912 $2.11 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $288,109 - $381,163	-11,930 Reduced 41.39%	16,893 $491,000
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $1.47 Million - $2.4 Million	-81,578 Reduced 73.89%	28,823 $794,000
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $847,792 - $1.59 Million	37,831 Added 52.13%	110,401 $2.47 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $226,684 - $331,610	5,611 Added 8.38%	72,570 $2.95 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $174,200 - $223,045	4,565 Added 7.32%	66,959 $3.24 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $1.66 Million - $2.71 Million	49,475 Added 382.96%	62,394 $2.38 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $37,832 - $48,680	904 Added 7.52%	12,919 $649,000
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $613,376 - $1.08 Million	-23,960 Reduced 66.6%	12,015 $481,000
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $1.02 Million - $1.37 Million	30,748 Added 588.25%	35,975 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $184,826 - $218,802	5,227 New	5,227 $208,000
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $173,924 - $226,262	-4,583 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $288,849 - $425,374	-6,172 Reduced 57.39%	4,583 $217,000
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $816,710 - $1.15 Million	-17,029 Reduced 61.29%	10,755 $656,000
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $2.27 Million - $2.85 Million	-49,898 Reduced 64.23%	27,784 $1.3 Million
Q2 2020 Aug 17, 2020	SELL	$42.56 - $54.98 $382,018 - $493,500	-8,976 Reduced 10.36%	77,682 $3.94 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $82,414 - $151,130	-2,546 Reduced 2.85%	86,658 $3.87 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $1.75 Million - $2.71 Million	54,175 Added 154.66%	89,204 $4.28 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $865,250 - $1.23 Million	-25,584 Reduced 42.21%	35,029 $1.19 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $6.45 Million - $8.19 Million	-182,015 Reduced 75.02%	60,613 $2.73 Million
Q1 2019 May 14, 2019	SELL	$28.09 - $39.49 $287,416 - $404,061	-10,232 Reduced 4.05%	242,628 $9.13 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $4.22 Million - $6.59 Million	141,602 Added 127.27%	252,860 $8.68 Million
Q3 2018 Nov 15, 2018	BUY	$33.9 - $47.77 $2.24 Million - $3.16 Million	66,154 Added 146.67%	111,258 $5.23 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $707,418 - $1.32 Million	27,526 Added 156.59%	45,104 $1.52 Million
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $100,342 - $187,294	-5,747 Reduced 24.64%	17,578 $476,000
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $761,375 - $1.05 Million	-50,289 Reduced 68.31%	23,325 $389,000
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $1.24 Million - $1.59 Million	73,614	73,614 $1.47 Million

Others Institutions Holding PTCT

# of Institutions

222

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.48B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Ptc Therapeutics, Inc. Transaction History